Skip Navigation


ToxSci Advance Access originally published online on February 19, 2004
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
79/1/41    most recent
kfh097v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Espandiari, P.
Right arrow Articles by Robertson, L. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Espandiari, P.
Right arrow Articles by Robertson, L. W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Toxicological Sciences 79, 41-46 (2004)
Toxicological Sciences vol. 79 no. 1 © Society of Toxicology; all rights reserved.

Initiating Activity of 4-Chlorobiphenyl Metabolites in the Resistant Hepatocyte Model

Parvaneh Espandiari*, Howard P. Glauert*,{dagger}, Hans-Joachim Lehmler*, Eun Y. Lee*,{ddagger}, Cidambi Srinivasan§ and Larry W. Robertson*,{dagger},1

* Graduate Center for Toxicology, {dagger} Graduate Center for Nutritional Sciences, {ddagger} Department of Pathology and Laboratory Medicine, and § Department of Statistics, University of Kentucky Medical Center, Lexington, Kentucky 40536

Received December 14, 2003; accepted January 26, 2004

We recently reported that several mono- to tetrachlorinated biphenyls have initiating activity in the livers of Fischer 344 rats. In the present study, we investigated the metabolic activation of one of those compounds, 4-chlorobiphenyl (PCB 3). Monohydroxy (400 µmol/kg), dihydroxy (200 µmol/kg), and quinone (100 µmol/kg) metabolites of PCB 3 were evaluated for their initiating activity. Fischer 344 male rats were fasted for 4 days; 24 h after feeding again, they were injected (ip) with metabolites, vehicle, or diethylnitrosamine (DEN, 20 or 40 mg/kg). All animals were treated with selection agents as follows: three daily p.o. doses of 2-acetylaminofluorene (2-AAF, 30 mg/kg), followed by a single p.o. dose of carbon tetrachloride (2 ml/kg) and three additional daily treatments of 2-AAF. Rats were killed 2 weeks after the last 2-AAF intubation. Livers were evaluated for changes in morphology, and the number and volume of {gamma}-glutamyl transpeptidase-positive foci were measured. Of the metabolites tested, only one monohydroxy and one quinoid metabolite showed initiating activity. The metabolic activation of PCB 3, therefore, proceeds via parahydroxylation and oxidation to the ortho 3,4-quinone, the ultimate carcinogen. This is the first report to demonstrate that specific PCB metabolites possess initiating activity in the rodent liver in vivo. The results support the conclusion that 4-OH PCB 3 and 3,4-BQ PCB 3 act as proximate and ultimate carcinogenic metabolites resulting from the bioactivation of PCB 3 in rat liver.

Key Words: polychlorinated biphenyls (PCBs); PCB 3; hepatocarcinogenesis; initiation; Solt-Farber; altered hepatic foci.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol SciHome page
M. A. Zettner, S. Flor, G. Ludewig, J. Wagner, L. W. Robertson, and L. Lehmann
Quinoid Metabolites of 4-Monochlorobiphenyl Induce Gene Mutations in Cultured Chinese Hamster V79 Cells
Toxicol. Sci., November 1, 2007; 100(1): 88 - 98.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L. Lehmann, H. L.Esch, P. A.Kirby, L. W.Robertson, and G. Ludewig
4-Monochlorobiphenyl (PCB3) induces mutations in the livers of transgenic Fisher 344 rats
Carcinogenesis, February 1, 2007; 28(2): 471 - 478.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.